Dr. Nora Janjan, MD, MPSA, MBA Joins STATinMED Team
Adding extensive clinical, HEOR, and editorial expertise
STATinMED Research, a leading health economics and outcomes research (HEOR) company, announces Dr. Nora Janjan’s appointment as Chief Medical Officer. Dr. Janjan, formerly Professor at MD Anderson Cancer Center, will play a key role in STATinMED’s expansion within oncology and cardiology and will contribute her real-world clinical and HEOR expertise to research projects in all medical disciplines. Dr. Janjan has authored more than 180 peer-reviewed articles, 61 book chapters, and has served on numerous editorial boards. She has had extensive experience in shaping regulatory and health policy, serving on the Medicare Coverage Advisory Committee, National Cancer Institute Central Institutional Review Board, and Institute for Clinical and Economic Research (ICER), while also participating in developing standards of healthcare and quality assurance guidelines with AMA’s Physician’s Consortium for Performance Improvement, National Comprehensive Cancer Network (NCCN), National Quality Forum, American Society of Clinical Oncology (ASCO), American Society of Radiation Oncology, and the Joint Commission on Accreditation of Healthcare Organizations (JCAHO).
Joining recently appointed Dr. Doug Brenner, PhD, MBA, President, the addition of Dr. Janjan augments the scope of research and analytical capabilities of STATinMED Research. Dr. Brenner states, “While our uniquely comprehensive access to multiple data sources, proven analytical expertise and proprietary algorithms are already well-known throughout the industry, Dr. Janjan will enhance value in all STATinMED’s service offerings through her clinical, academic, public policy and HEOR expertise. Already working on the cutting edge of analytics, Dr. Janjan’s guidance adds an exciting new level of depth and versatility to our data team.”
Dr. Janjan’s medical academic experience includes tenured Professor in Radiation Oncology, and Symptom Research at MD Anderson Cancer Center where she served as Vice Chair of the Institutional Review Board, and Director of Health Care Policy in Radiation Oncology. She has held leadership positions in the American Society for Radiation Oncology (ASTRO) as past President, and the American Society of Clinical Oncology’s (ASCO) Conquer Cancer Foundation Board of Directors, and the Radiological Society of North America (RSNA).
